BFLY on NYSE
Butterfly Network, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Nano-X Imaging, Hologic or GE HealthCare, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
46.9%Gross margin2
-88.5%Operating margin2
-79.0%Net margin2
19.0%Revenue growth, 20252
-39.3%Return on equity2
-$16.0MFree cash flow2
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product brought in 65% of the revenue Butterfly Network, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Product | $40.0M | $54.2M | $63.4M |
| Software And Other Services | $25.9M | $27.9M | $34.2M |
Regions
United States brought in 79% of the revenue Butterfly Network, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $52.1M | $63.4M | $77.4M |
| Outside the United States | $13.8M | $18.6M | $20.2M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue53¢$51.9M
- Research and development37¢$36.3M
- Other costs10¢$9.4M
- Income tax0¢$110.0K
Out of $97.6M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total revenue | $97.6M | $82.1M | $65.9M |
| Total cost of revenue | $51.9M | $33.2M | $49.0M |
| Gross profit | $45.7M | $48.8M | $16.9M |
| Research and development | $36.3M | $37.8M | $55.6M |
| Sales and marketing | $45.9M | $41.6M | $39.1M |
| General and administrative | $39.2M | $39.8M | $49.6M |
| Other | $10.8M | $4.1M | $18.2M |
| Total operating expenses | $132.1M | $123.2M | $162.5M |
| Loss from operations | -$86.4M | -$74.4M | -$145.6M |
| Interest income | $5.9M | $5.0M | $7.5M |
| Interest expense | -$1.5M | -$1.3M | $0 |
| Change in fair value of warrant liabilities | $2.3M | -$1.9M | $4.5M |
| Other income (expense), net | $2.8M | -$13.0K | -$2.0K |
| Loss before provision for income taxes | -$77.0M | -$72.5M | -$133.6M |
| Provision (benefit) for income taxes | $110.0K | -$32.0K | $82.0K |
| Net loss and comprehensive loss | -$77.1M | -$72.5M | -$133.7M |
| Net loss and comprehensive loss | -$77.1M | -$72.5M | -$133.7M |
| Net loss per common share attributable to Class A and B common stockholders - basic (in dollars per share) | -$0.31 | -$0.34 | -$0.65 |
| Net loss per common share attributable to Class A and B common stockholders - diluted (in dollars per share) | -$0.31 | -$0.34 | -$0.65 |
| Weighted-average common shares used to compute net loss per share attributable to Class A and Class B common stockholders - basic (in shares) | 247.1M shares | 211.7M shares | 205.4M shares |
| Weighted-average common shares used to compute net loss per share attributable to Class A and Class B common stockholders - diluted (in shares) | 247.1M shares | 211.7M shares | 205.4M shares |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $150.5M | $88.8M | |
| Accounts receivable, net of allowance for credit losses of $1,389 and $2,583 at December 31, 2025 and December 31, 2024, respectively | $26.7M | $20.8M | |
| Inventories | $61.4M | $70.8M | |
| Current portion of vendor advances | $2.1M | $5.5M | |
| Prepaid expenses and other current assets | $8.4M | $6.7M | |
| Total current assets | $249.1M | $192.6M | |
| Property and equipment, net | $16.6M | $19.5M | |
| Intangible assets, net | $7.5M | $8.9M | |
| Non-current portion of vendor advances | $5.0M | $15.0M | |
| Operating lease assets | $12.7M | $14.2M | |
| Other non-current assets | $5.7M | $5.8M | |
| Total assets | $296.5M | $256.1M | |
| Accounts payable | $5.4M | $4.2M | |
| Deferred revenue, current | $26.9M | $16.1M | |
| Accrued purchase commitments, current | $131.0K | $131.0K | |
| Warrant liabilities, current | $413.0K | $0 | |
| Accrued expenses and other current liabilities | $32.2M | $27.7M | |
| Total current liabilities | $65.1M | $48.2M | |
| Deferred revenue, non-current | $9.4M | $7.3M | |
| Warrant liabilities, non-current | $0 | $2.7M | |
| Operating lease liabilities | $17.7M | $20.4M | |
| Other non-current liabilities | $8.3M | $8.6M | |
| Total liabilities | $100.6M | $87.2M | |
| Additional paid-in capital | $1.1B | $970.9M | |
| Accumulated deficit | -$879.2M | -$802.1M | |
| Total stockholders equity | $196.0M | $168.8M | $220.1M |
| Total liabilities and stockholders equity | $296.5M | $256.1M | |
| Accounts receivable, net of allowance for doubtful accounts | $1.4M | $2.6M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$77.1M | -$72.5M | -$133.7M |
| Depreciation, amortization, and impairments | $8.1M | $10.3M | $10.6M |
| Non-cash interest expense | $1.5M | $1.3M | $0 |
| Write-down of inventories | $8.0M | $15.0K | $21.1M |
| Write-down of vendor advances | $9.6M | $0 | $0 |
| Stock-based compensation expense | $23.4M | $21.0M | $27.5M |
| Change in fair value of warrant liabilities | -$2.3M | $1.9M | -$4.5M |
| Gain on lease termination | $0 | $0 | -$214.0K |
| Other | $799.0K | $1.1M | $633.0K |
| Accounts receivable | -$6.8M | -$8.5M | -$162.0K |
| Inventories | $1.4M | $2.2M | -$34.1M |
| Prepaid expenses and other assets | -$1.6M | $1.3M | $3.0M |
| Vendor advances | $3.9M | -$2.5M | $17.1M |
| Accounts payable | $1.2M | -$841.0K | -$1.9M |
| Deferred revenue | $12.8M | $435.0K | $2.2M |
| Accrued purchase commitments | $0 | $0 | -$2.0M |
| Change in operating lease assets and liabilities | -$855.0K | -$750.0K | -$635.0K |
| Accrued expenses and other liabilities | $5.1M | $3.8M | -$3.6M |
| Net cash used in operating activities | -$12.7M | -$41.7M | -$98.8M |
| Purchases of marketable securities | $0 | $0 | -$297.0K |
| Sales of marketable securities | $0 | $0 | $76.5M |
| Purchases of property, equipment, and intangible assets, including capitalized software | -$3.3M | -$2.7M | -$5.8M |
| Sales of property and equipment | $0 | $36.0K | $10.0K |
| Net cash provided by (used in) investing activities | -$3.3M | -$2.7M | $70.4M |
| Proceeds from exercise of stock options | $816.0K | $64.0K | $228.0K |
| Proceeds from employee stock purchase plan | $1.4M | $495.0K | $0 |
| Net proceeds from share offering | $81.0M | $0 | $0 |
| Payments to tax authorities for restricted stock units withheld | -$2.8M | -$739.0K | $0 |
| Payments on technology license commitment | -$2.7M | -$1.3M | $0 |
| Net cash provided by (used in) financing activities | $77.8M | -$1.5M | $228.0K |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $61.7M | -$45.9M | -$28.2M |
| Interest paid | $810.0K | $190.0K | $0 |
| Acquisition of property, equipment, and intangible assets, including capitalized software | $396.0K | $470.0K | $9.2M |
Former names
- Longview Acquisition Corp.Feb 26, 2020 to Feb 11, 20213
Recent filings
- Oct 8, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Oct 6, 2026144
- Oct 6, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Oct 5, 20268-K
- Oct 2, 2026144
- Sep 24, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Sep 23, 2026144
- Sep 23, 2026144
- Sep 22, 2026144
- Sep 22, 2026144
- Sep 9, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Sep 9, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Sep 4, 2026144
- Sep 4, 2026144
- Sep 4, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11